12163 related articles for article (PubMed ID: 10586378)
1. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
2. Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1999; 19(4B):3293-314. PubMed ID: 10652626
[TBL] [Abstract][Full Text] [Related]
3. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical detection of leukocyte-associated and apoptosis-related antigen expression in childhood brain tumors.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Crit Rev Oncol Hematol; 2001; 39(1-2):3-16. PubMed ID: 11418297
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469
[TBL] [Abstract][Full Text] [Related]
6. MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2002; 16(6):583-8. PubMed ID: 12494904
[TBL] [Abstract][Full Text] [Related]
7. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
8. Role of nonspecific cytotoxic cells in the induction of programmed cell death of pathogenic protozoans: participation of the Fas ligand-Fas receptor system.
Jaso-Friedmann L; Leary JH; Evans DL
Exp Parasitol; 2000 Oct; 96(2):75-88. PubMed ID: 11052866
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical detection of members of the caspase cascade of apoptosis in high-grade astrocytomas.
Bodey B; Bodey V; Siegel SE; Nasir A; Coppola D; Hakam A; Kaiser HE
In Vivo; 2004; 18(5):593-602. PubMed ID: 15523899
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
12. Malignant lymphoma arising from natural killer cells: report of the first case in 1970 and newer developments in the FasL-->FasR system.
Sinkovics JG
Acta Microbiol Immunol Hung; 1997; 44(3):295-303. PubMed ID: 9468734
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase expression in childhood astrocytomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(5A):3287-92. PubMed ID: 11062755
[TBL] [Abstract][Full Text] [Related]
14. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
15. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
16. Conversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid.
Danforth DN; Zhu Y
Breast Cancer Res Treat; 2005 Nov; 94(1):81-91. PubMed ID: 16136269
[TBL] [Abstract][Full Text] [Related]
17. Expression of proline-directed protein kinase, (p34cdc2/p58cyclin A), a novel cell proliferation marker in childhood brain tumors.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2002; 16(6):589-94. PubMed ID: 12494905
[TBL] [Abstract][Full Text] [Related]
18. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 (COX-2) overexpression in childhood brain tumors.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2006; 20(4):519-25. PubMed ID: 16900783
[TBL] [Abstract][Full Text] [Related]
20. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
